Re: TASHA - Advancing Remote Patient Monitoring for Diabetic Foot Ulcers: A Patient-Centered Approach application

糖尿病是全球第九大死因，也是心脏相关死亡的重要共病，是一个重大的健康问题。仅在英国，超过400万被诊断患有糖尿病的人面临着发展糖尿病足溃疡（DFU）的风险增加了23倍。令人担忧的是，10%的DFU导致截肢，两年内死亡率为50%。全球糖尿病患者超过4.5亿，预计到2030年将增长到5.78亿。为了解决这一紧迫问题，医疗智能集团（Medical Intelligence Group，简称IMG）提供了一个创新的三大支柱解决方案，利用新型数字和数据支持工具更准确地诊断病情，对患者进行适当的治疗，并增加综合和多模式方法的应用，以确定风险，诊断，并预测预后结果。ESTA的解决方案包括远程监控技术，早期溃疡检测系统和AI预测建模。通过改善溃疡监测和实现及时治疗，ESTA的解决方案显着改善患者的结果，缓解压力，并为NHS节省成本。此外，早期发现恶化的溃疡减少了截肢的需要，使患者在社会和经济上受益。Etienne的创新方法填补了未满足的临床需求，并解决了糖尿病足溃疡的紧迫挑战。通过利用新的数字化工具，该公司旨在在对抗这种疾病、改善患者福祉和减轻医疗负担方面取得实质性进展。

Diabetes, the 9th leading cause of death globally and a significant co-morbidity to cardiac-related deaths, poses a major health concern. In the UK alone, over 4 million individuals diagnosed with diabetes face a staggering 23-fold increased risk of developing diabetic foot ulcers (DFUs). Alarmingly, 10% of these DFUs lead to foot amputations, with a mortality rate of 50% within two years. Globally, there are over 450 million diabetics, projected to grow to 578 million by 2030\.To address this urgent issue, Medical Intelligence Group (MIG) offers an innovative three-pillar solution that utilises novel digital and data-enabled tools to more accurately diagnose conditions, stratify patients to appropriate treatments, and increase the application of integrated and multi-modal approaches to determine risk, diagnosis, and predict prognostic outcomes.MIG's solution includes remote monitoring technology, early ulcer detection systems, and AI predictive modelling. By improving ulcer monitoring and enabling timely treatments, MIG's solution significantly improves patient outcomes, relieves stress, and generates cost savings for the NHS. Additionally, the early detection of deteriorating ulcers reduces the need for amputations, benefiting patients both socially and economically.MIG's innovative approach fills an unmet clinical need and addresses the pressing challenge of diabetic foot ulcers. By leveraging novel digital tools, MIG aims to make substantial progress in combating this condition, improving patient well-being, and alleviating the healthcare burden.